HGF and neoplasm: Time-dependent changes of serum HGF during the treatment with trastuzumab may provide significant information in terms of an individual doctor's decisions to select the most appropriate treatment as personalized medicine and the serum markers are less invasive compared with the biopsy or surgical resection of tumor tissues for metastatic stage of GC patients.